"Bausch Health Companies Inc. shares experienced a 1.65% decline in premarket trading amid a generally stable TSX, despite a notable $300 million insider purchase that suggests confidence from management. The overall sentiment remains cautious, with a low average sentiment score of 0.26, indicating potential risks and uncertainty surrounding the company's performance."